Delivery Order SPE2DB22D2211-SPE2DB24FNTS7
Award Date
6/19/24
Potential Completion Date
6/20/24
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with a range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The $10,302.24 Firm Fixed Price Delivery Order contract covers the supply of Ondansetron HCL 4 mg tablets, with a completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,989.77 firm fixed-price delivery order is for 4,564,689,910 units of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,008,244 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $11,330.40 firm fixed price delivery order has a June 27, 2024 completion date. As a subsidiary of one of the largest pharmaceutical distributors, Amerisourcebergen leverages its extensive supply chain to fulfill government contracts, with a focus on serving the Department of Defense (DoD)...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $4,724.30 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 24, 2024 with a completion date of May 28, 2024. The contract is not set aside for any particular business type. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,911.23, is a Firm Fixed Price Delivery Order for the supply of 4 mg Ondansetron Orally Disintegrating Tablets. The contract has an ultimate completion date of March 3, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,820,315 units of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The $1,284.83 contract has a firm fixed price and was awarded on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the purchase of 4,567,175,269 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $12,156.98 firm fixed-price delivery order has a completion date of February 6, 2025 and is not designated under any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,607.11 Firm Fixed Price Delivery Order contract is for the supply of 4,567,146,492 units of Ondansetron HCL 4 mg tablets. The award has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $16,436.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a completion date of December 10, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...